SCHEDULE 13D

Company

Inhibitor Therapeutics, Inc.

Filed

September 29, 2000

Accession Number

0000916641-00-001415

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →